Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Tsumura & Co ( (JP:4540) ) has provided an announcement.
Tsumura & Co. has finalized the offer price for a secondary offering of its common shares, aiming to raise over 10 billion yen. This move is part of a strategic effort to strengthen its financial position and expand its market reach, with a significant portion of shares being sold to foreign investors in Europe and Asia.
More about Tsumura & Co
Tsumura & Co. operates in the pharmaceutical industry, primarily focusing on the production and sale of Kampo medicines, which are traditional Japanese herbal medicines. The company is listed on the TSE Prime Market and targets both domestic and international markets, excluding the US and Canada.
YTD Price Performance: -4.67%
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $2.18B
For a thorough assessment of 4540 stock, go to TipRanks’ Stock Analysis page.